Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
C 0.900 CausalMutation CLINVAR A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. 7906866

1994

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
C 0.900 CausalMutation CLINVAR Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. 7906417

1994

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
C 0.900 CausalMutation CLINVAR Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. 7824936

1995

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
C 0.900 GeneticVariation CLINVAR RET activation by germline MEN2A and MEN2B mutations. 8570194

1995

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
0.900 GeneticVariation UNIPROT The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. 8918855

1996

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
C 0.900 CausalMutation CLINVAR Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome). 8880581

1996

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
C 0.900 CausalMutation CLINVAR Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain. 9242375

1997

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
0.900 GeneticVariation BEFREE They are represented by the Met918Thr substitution (exon 16) typical of Multiple Endocrine Neoplasia type 2B (MEN2B) and, to a lesser extent, by nucleotide changes occurring at one of five critical cysteine residues (exons 10 and 11) typical of MEN type 2A (MEN2A). 9191060

1997

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
0.900 GeneticVariation BEFREE Mutation analysis of exon 16 of the RET proto-oncogene revealed germline M918T and thus, a molecular diagnosis of multiple endocrine neoplasia type 2B (MEN 2B). 10369718

1999

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
C 0.900 CausalMutation CLINVAR Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma. 10445857

1999

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
0.900 GeneticVariation BEFREE MEN2B is caused by a specific mutation (Met918-->Thr) in the RET receptor tyrosine kinase. 10023663

1999

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
0.900 GeneticVariation BEFREE Thus, while our results support the conclusion that the Met918Thr substitution is responsible for MEN2B, they suggest that the substrate specificity of the RET kinase does not interfere with its normal role in the development of the kidneys and enteric nervous system. 10675330

2000

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
C 0.900 CausalMutation CLINVAR A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations. 10679286

2000

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
0.900 GeneticVariation UNIPROT Guidelines for diagnosis and therapy of MEN type 1 and type 2. 11739416

2001

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
0.900 GeneticVariation BEFREE All MEN 2B patients showed an ATG to ACG (Met918Thr) mutation. 11900218

2002

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
0.900 GeneticVariation BEFREE More than 95% of MEN2B patients also had a predominant mutation type at codon 918 (Met-->Thr). 11839664

2002

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
0.900 GeneticVariation BEFREE In multiple endocrine neoplasia 2B (MEN-2B) patients expressing RET(M918T), nuclear enrichment of STAT3 and elevated expression of CXCR4 was detected in metastatic thyroid C-cell carcinoma in the liver. 15485908

2004

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
C 0.900 CausalMutation CLINVAR External ophthalmic findings in multiple endocrine neoplasia type 2B. 15281979

2004

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
0.900 GeneticVariation BEFREE One patient having a mutation in exon 16 (Met918Thr) presented with the MEN2B phenotype, six patients from two families had hereditary MTC without pheochromocytoma (pheo) and primary hyperparathyroidism (PHPT), whereas 33 patients from 15 families showed the MEN2A phenotype. 16865647

2006

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
0.900 GeneticVariation BEFREE Although there were no syndromic features or a positive family history, mutation analysis of the RET proto-oncogene showed a de novo germline Met918Thr mutation in both patients, confirming the diagnosis of multiple endocrine neoplasia type 2B (MEN 2B). 16808642

2006

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
C 0.900 CausalMutation CLINVAR Medullary thyroid carcinoma in a 2-month-old male with multiple endocrine neoplasia 2B and symptoms of pseudo-Hirschsprung disease: a case report. 17848262

2007

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
0.900 GeneticVariation BEFREE More than 90% of M918T carriers with multiple endocrine neoplasia type 2B (MEN 2B) harbor de novo mutations in the REarranged during Transfection (RET) protooncogene. 19041016

2008

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
C 0.900 CausalMutation CLINVAR Medullary thyroid carcinoma identified within the first year of life in children with hereditary multiple endocrine neoplasia type 2A (codon 634) and 2B. 19240193

2009

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
0.900 GeneticVariation UNIPROT Medullary thyroid cancer: management guidelines of the American Thyroid Association. 19469690

2009

dbSNP: rs74799832
rs74799832
RET
Multiple Endocrine Neoplasia Type 2b
0.900 GeneticVariation BEFREE A family with MEN-2B due to RET-A883F mutation displayed a less aggressive form of MTC than what is usually seen in patients with RET-M918T mutation. 21186952

2011